Domov › Srpastocelična anemija › Texas
Klinične študije za Srpastocelična anemija v Texas
11 študij za Srpastocelična anemija išče udeležence na lokacijah v Texas.
Mesta v Texas
Uradno besedilo študije (angleško)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
Vključevanje udeležencevFaza 3
Starost 12–100 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06439082A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
Vključevanje udeležencevFaza 3
Starost 2 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- UT Health University of Texas, Houston
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- UT Health Science Center, Houston
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 12–55 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06546670ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Blood and Cancer Center of Central Texas, Austin
- North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
- North Texas Comprehensive Hemophilia Treatment Center, Dallas
- in še 3
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT04398628The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Baylor College of Medicine- Site Number : 8400055, Houston
Vključevanje udeležencevFaza 3
Starost 10–65 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06975865Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
- UT San Antonio (NT-DMT), San Antonio
Vključevanje udeležencevOpazovalna študija
Starost 3–20 · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT06941389Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Site # 8400004, Houston
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT07247188Sickle Cell Kidney Biorepository
- Parkland Memorial Hospital, Dallas
- University of Texas Southwestern Medical Center, Dallas
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT07064174Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Baylor College of Medicine, Houston
Vključevanje udeležencevFaza 2
Starost 15–40 · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT06260891Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Texas at Houston, Houston
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 22. jun. 2025 · NCT06385886Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.